Overview

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Cilostazol